Barbara Frossi1, Claudio Tripodo2, Carla Guarnotta2, Antonio Carroccio3, Marco De Carli4, Stefano De Carli4, Marco Marino5, Antonino Calabrò6, Carlo E Pucillo7. 1. Department of Medical and Biological Sciences, University of Udine, Udine, Italy. 2. Department of Health Science, University Hospital of Palermo, Palermo, Italy. 3. Department of Internal Medicine and Specialist, University Hospital of Palermo, Palermo, Italy. 4. Second Unit of Internal Medicine, University of Udine, Udine, Italy. 5. Department of Gastroenterology and Digestive Endoscopy, University Hospital of Udine, Udine, Italy. 6. Department of Experimental and Clinical Biomedical Sciences "Mario Serio," University Hospital of Florence, Florence, Italy; Tuscany Referral Center for Adult Coeliac Disease, AOU Careggi, Florence, Italy. 7. Department of Medical and Biological Sciences, University of Udine, Udine, Italy. Electronic address: carlo.pucillo@uniud.it.
Abstract
BACKGROUND: Celiac disease (CD) is an immune-mediated disorder characterized by an accumulation of immune cells in the duodenal mucosa as a consequence of both adaptive and innate immune responses to undigested gliadin peptides. Mast cells (MCs) are innate immune cells that are a major source of costimulatory signals and inflammatory mediators in the intestinal mucosa. Although MCs have previously been associated with CD, functional studies have never been performed. OBJECTIVE: We aimed at evaluating the role of MCs in the pathogenesis of CD. METHODS: Intestinal biopsy specimens of patients with CD were scored according to the Marsh classification and characterized for leukocyte infiltration and MC distribution. Moreover, MC reactivity to gliadin and its peptides was characterized by using in vitro assays. RESULTS: Infiltrating MCs were associated with the severity of mucosal damage, and their numbers were increased in patients with higher Marsh scores. MCs were found to directly respond to nonimmunodominant gliadin fragments by releasing proinflammatory mediators. Immunohistochemical characterization of infiltrating MCs and the effects of gliadin peptides on intestinal MCs indicated an increase in proinflammatory MC function in advanced stages of the disease. This was also associated with increased neutrophil accumulation, the prevalence of M1 macrophages, and the severity of tissue damage. CONCLUSION: We provide a description of the progressive stages of CD, in which MCs are the hallmark of the inflammatory process. Thus the view of CD should be revised, and the contribution of MCs in the onset and progression of CD should be reconsidered in developing new therapeutic approaches.
BACKGROUND:Celiac disease (CD) is an immune-mediated disorder characterized by an accumulation of immune cells in the duodenal mucosa as a consequence of both adaptive and innate immune responses to undigested gliadin peptides. Mast cells (MCs) are innate immune cells that are a major source of costimulatory signals and inflammatory mediators in the intestinal mucosa. Although MCs have previously been associated with CD, functional studies have never been performed. OBJECTIVE: We aimed at evaluating the role of MCs in the pathogenesis of CD. METHODS: Intestinal biopsy specimens of patients with CD were scored according to the Marsh classification and characterized for leukocyte infiltration and MC distribution. Moreover, MC reactivity to gliadin and its peptides was characterized by using in vitro assays. RESULTS: Infiltrating MCs were associated with the severity of mucosal damage, and their numbers were increased in patients with higher Marsh scores. MCs were found to directly respond to nonimmunodominant gliadin fragments by releasing proinflammatory mediators. Immunohistochemical characterization of infiltrating MCs and the effects of gliadin peptides on intestinal MCs indicated an increase in proinflammatory MC function in advanced stages of the disease. This was also associated with increased neutrophil accumulation, the prevalence of M1 macrophages, and the severity of tissue damage. CONCLUSION: We provide a description of the progressive stages of CD, in which MCs are the hallmark of the inflammatory process. Thus the view of CD should be revised, and the contribution of MCs in the onset and progression of CD should be reconsidered in developing new therapeutic approaches.
Authors: Amelie Therrien; Jocelyn A Silvester; Daniel A Leffler; Ciaran P Kelly Journal: Clin Gastroenterol Hepatol Date: 2019-03-21 Impact factor: 11.382
Authors: Mercé Albert-Bayo; Irene Paracuellos; Ana M González-Castro; Amanda Rodríguez-Urrutia; María J Rodríguez-Lagunas; Carmen Alonso-Cotoner; Javier Santos; María Vicario Journal: Cells Date: 2019-02-08 Impact factor: 6.600
Authors: Carlo Catassi; Armin Alaedini; Christian Bojarski; Bruno Bonaz; Gerd Bouma; Antonio Carroccio; Gemma Castillejo; Laura De Magistris; Walburga Dieterich; Diana Di Liberto; Luca Elli; Alessio Fasano; Marios Hadjivassiliou; Matthew Kurien; Elena Lionetti; Chris J Mulder; Kamran Rostami; Anna Sapone; Katharina Scherf; Detlef Schuppan; Nick Trott; Umberto Volta; Victor Zevallos; Yurdagül Zopf; David S Sanders Journal: Nutrients Date: 2017-11-21 Impact factor: 5.717
Authors: Enzo Ierardi; Giuseppe Losurdo; Domenico Piscitelli; Floriana Giorgio; Annacinzia Amoruso; Andrea Iannone; Mariabeatrice Principi; Alfredo Di Leo Journal: Gastroenterol Hepatol Bed Bench Date: 2018